ORGANOVO HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9602 USD | +0.67% |
|
-2.34% | -13.50% |
| 05-31 | Organovo Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
| 04-15 | Organovo's fatty liver disease drug meets main goal in mid-stage study | RE |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ORGANOVO HOLDINGS, INC. | Other Biotechnology & Medical Research | +0.67% | -2.34% | -13.50% | -43.85% | -89.46% | 12.44M |  | |  |
- Stock Market
- Equities
- ONVO Stock
- Charts Organovo Holdings, Inc.
- Relative Strength Chart
